BNYN.US Banyan Corp
- Market cap
- -
- P/E
- 0.0x
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2008.
Is BNYN.US undervalued?
Graham numberThe Graham number of Banyan Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Banyan Corp fundamental analysis
No fundamental analysis for Banyan Corp yet.
Banyan Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Banyan Corp
Banyan Corp., through its subsidiaries, engages in the franchising of chiropractic clinics in North America. It provides practice development training and assistance to chiropractors, as well as offers franchise support and related services to franchisees and licensees. The company also offers diagnostic testing services. Banyan Corporation provides nerve conduction velocity (NCV) testing to patients through health care professionals, such as doctors and chiropractors. The N…
Full company profileBanyan Corp financial statements
2008 annualized: Fiscal year 2008 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2008, the balance sheet is the latest quarter. Figures change when the annual report is published.
Banyan Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 141K | 512K | 409K | 798K | 1.75M | 466K | 1.09M | 5.45M | 5.00M | 2.54M |
| Gross Profit | 88.6K | 267K | 234K | 458K | 664K | 359K | 825K | 5.40M | 5.00M | 2.54M |
| Operating Income | -577K | -1.34M | -812K | -834K | -3.80M | -2.21M | -2.52M | -351K | -1.59M | -661K |
| EBITDA | -554K | -1.28M | -771K | -729K | -3.31M | -1.91M | -428K | 1.38M | 584K | -616K |
| Net Income | -539K | -2.24M | -970K | -465K | -3.92M | -2.46M | -4.65M | -4.08M | -5.48M | -3.66M |
| EPS | -453 | -2,183 | -827 | -257 | -805 | -430 | -494 | -176 | -18 | -0.78 |
| Balance Sheet | ||||||||||
| Total Assets | 413K | 823K | 191K | 1.58M | 1.04M | 1.05M | 1.86M | 5.23M | 4.50M | 3.76M |
| Total Liabilities | 715K | 1.09M | 1.22M | 2.15M | 2.18M | 2.44M | 2.56M | 4.44M | 4.52M | 5.45M |
| Shareholders' Equity | -303K | -271K | -1.03M | -573K | -1.13M | -1.40M | -702K | 793K | -15.5K | -1.69M |
| Cash & Short-term Investments | 32.4K | 2.88K | 49.8K | 49.2K | 10.2K | 945.00 | 2.21K | 130K | 52.9K | 66.6K |
| Total Debt | 272K | 328K | 429K | 1.57M | 1.25M | 782K | 1.31M | 3.18M | 3.66M | 4.36M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -337K | -19.4K | -190K | -97.6K | -633K | -1.25M | -1.14M | -837K | -1.81M | 664K |
| Capital Expenditure | 95.2K | 25.0K | 3.42K | 900K | 3.10K | 1.08K | 700K | 1.08K | 25.8K | 4.43K |
| Free Cash Flow | -432K | -44.4K | -194K | -998K | -636K | -1.25M | -1.84M | -838K | -1.84M | 664K |
| Ratios | ||||||||||
| ROE | - | - | - | - | - | - | - | -514.6% | - | - |
| ROA | -130.6% | -272.0% | -509.0% | -29.5% | -376.2% | -235.2% | -249.6% | -78.0% | -121.8% | -97.4% |
| Net Profit Margin | -381.7% | -437.5% | -237.0% | -58.3% | -223.6% | -528.2% | -425.9% | -74.9% | -109.6% | -144.0% |
| Debt to Equity | - | - | - | - | - | - | - | 4.01x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Banyan Corp dividends
Banyan Corp has not paid dividends in the last 9 fiscal years.
Last stock split: 1:100 on Mar 18, 2010.
Who owns Banyan Corp
Ownership data of Banyan Corp is not available yet.
Banyan Corp company profile
- Company name
- Banyan Corp
- Ticker
- BNYN.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 20
- Fiscal year end
- December
- Address
- 9025 Wilshire Boulevard, Beverly Hills, CA, United States, 90211
- Phone
- 800-808-0899
- Website
- -
About Banyan Corp
Banyan Corp., through its subsidiaries, engages in the franchising of chiropractic clinics in North America. It provides practice development training and assistance to chiropractors, as well as offers franchise support and related services to franchisees and licensees. The company also offers diagnostic testing services. Banyan Corporation provides nerve conduction velocity (NCV) testing to patients through health care professionals, such as doctors and chiropractors. The NCV testing measures the transmission of nerve impulses through the body, identifies problems in the nervous system, and enables to substantiate the cost of treatment to patients and their insurers. In addition, it manufactures and markets the VT3000, a nerve testing system for the diagnosis of neuropathies, which are diseases of the peripheral nerves and parts of the spine, as well as nerve irritation and other damage to the nervous system of a patient. The company was founded in 1978 and is based in Beverly Hills, California.
Banyan Corp management
2- Mr. Michael J. Gelmon LL.B.Chairman & CEO · born 1965
- Mr. Cory H. GelmonPresident, COO, CFO, Principal Accounting Officer, Chief Legal Officer, Secretary & Director · born 1960